Skip to main content
. 2022 Oct 20;298(12):102622. doi: 10.1016/j.jbc.2022.102622

Figure 2.

Figure 2

Fibroproliferative diseases: Various organs develop fibrotic scars as a result of constant tissue damage and insults. FSGS, focal segmental glomerlosclerosis; NASH, nonalcoholic steatohepatitis; AMD, age-related macular degeneration; COPD, chronic obstructive pulmonary disease. (Adapted from Karsdal et al, 2014 Alimentary Pharmacology and Therapeutics, 40: 233–249)